Key players operating in the India And Oman Pharmaceutical Industry Market Size are Accenture plc, Cognizant Technology Solutions, ATOS SE, Catalent, Inc., Covance, Inc., Boehringer Ingelheim GmbH, Genpact Limited, Lonza Group, PAREXEL International Corporation, Quintiles Transnational Corporation, Abbvie, Inc., Baxter International Inc., Dr. Reddy€TMs Laboratories Ltd., Aurobindo Pharma, Pfizer, Inc., The Almac Group, Teva Pharmaceutical Industries Ltd. and Piramal Enterprises Ltd. The rising prevalence of chronic diseases and increasing healthcare spending has been driving the demand for pharmaceutical drugs in both domestic and international markets. Leading Indian pharmaceutical companies are expanding their manufacturing footprint to Oman through joint ventures and acquisitions to leverage the strategic geographic location of Oman for exports to Asian and African countries.

The current geopolitical situation is significantly impacting the growth of India and Oman pharmaceutical industry market. To sustain growth over the next few years, companies will need to diversify their operations within the region, localize production and establish new strategic partnerships to minimize cross-border dependencies. While urban centers in North India and Oman currently hold the highest market share in value terms, Southern states in India and underdeveloped parts of Oman are emerging as the fastest growing geographical regions driven by supportive governmental policies.

Explore Our More Blogs on India and Oman Pharmaceutical Industry Market

Also Read Related Article on Safety and Security Drones Market